“…Effective delivery of Biopharmaceutics Classification System class II active pharmaceutical ingredients (APIs), defined as having high permeability and low solubility, 1 is challenging due to their low bioavailability. 2 To enhance their bioavailability, several technologies have been examined, such as particle size reduction, [3][4][5] cyclodextrin complexes, 6 polymeric micelles, 7 freeze-dried liposomes, 8 solid lipid nanoparticles, 9 and amorphous solid dispersions (ASDs). 10,11 Among them, amorphous solids dispersions technology has been proved to be one of the promising solutions.…”